Literature DB >> 19025787

Modifications to the Patient Rule-Induction Method that utilize non-additive combinations of genetic and environmental effects to define partitions that predict ischemic heart disease.

Greg Dyson1, Ruth Frikke-Schmidt, Børge G Nordestgaard, Anne Tybjaerg-Hansen, Charles F Sing.   

Abstract

This article extends the Patient Rule-Induction Method (PRIM) for modeling cumulative incidence of disease developed by Dyson et al. (Genet Epidemiol 31:515-527) to include the simultaneous consideration of non-additive combinations of predictor variables, a significance test of each combination, an adjustment for multiple testing and a confidence interval for the estimate of the cumulative incidence of disease in each partition. We employ the partitioning algorithm component of the Combinatorial Partitioning Method to construct combinations of predictors, permutation testing to assess the significance of each combination, theoretical arguments for incorporating a multiple testing adjustment and bootstrap resampling to produce the confidence intervals. An illustration of this revised PRIM utilizing a sample of 2,258 European male participants from the Copenhagen City Heart Study is presented that assesses the utility of genetic variants in predicting the presence of ischemic heart disease beyond the established risk factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19025787      PMCID: PMC2676926          DOI: 10.1002/gepi.20383

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  17 in total

1.  Nomenclature for the description of human sequence variations.

Authors:  J T den Dunnen; S E Antonarakis
Journal:  Hum Genet       Date:  2001-07       Impact factor: 4.132

2.  Genes, environment, and cardiovascular disease.

Authors:  Charles F Sing; Jari H Stengård; Sharon L R Kardia
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-05-01       Impact factor: 8.311

3.  Realizing the promise of genomics in biomedical research.

Authors:  Alan E Guttmacher; Francis S Collins
Journal:  JAMA       Date:  2005-09-21       Impact factor: 56.272

4.  From genotype to phenotype: systems biology meets natural variation.

Authors:  Philip N Benfey; Thomas Mitchell-Olds
Journal:  Science       Date:  2008-04-25       Impact factor: 47.728

5.  Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.

Authors:  Philippa J Talmud; Emma Hawe; Steve Martin; Michael Olivier; George J Miller; Edward M Rubin; Len A Pennacchio; Steve E Humphries
Journal:  Hum Mol Genet       Date:  2002-11-15       Impact factor: 6.150

6.  Epistasis and its contribution to genetic variance components.

Authors:  J M Cheverud; E J Routman
Journal:  Genetics       Date:  1995-03       Impact factor: 4.562

7.  SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.

Authors:  William T Wright; Ian S Young; D Paul Nicholls; Chris Patterson; Kelly Lyttle; Colin A Graham
Journal:  Atherosclerosis       Date:  2005-08-25       Impact factor: 5.162

8.  Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype.

Authors:  R Frikke-Schmidt; B G Nordestgaard; B Agerholm-Larsen; P Schnohr; A Tybjaerg-Hansen
Journal:  J Lipid Res       Date:  2000-11       Impact factor: 5.922

9.  Contribution of regulatory and structural variations in APOE to predicting dyslipidemia.

Authors:  Jari H Stengård; Sharon L R Kardia; Sara C Hamon; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen; Veikko Salomaa; Eric Boerwinkle; Charles F Sing
Journal:  J Lipid Res       Date:  2005-11-29       Impact factor: 5.922

Review 10.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb
View more
  6 in total

1.  Subgroups at high risk for ischaemic heart disease:identification and validation in 67 000 individuals from the general population.

Authors:  Ruth Frikke-Schmidt; Anne Tybjærg-Hansen; Greg Dyson; Christiane L Haase; Marianne Benn; Børge G Nordestgaard; Charles F Sing
Journal:  Int J Epidemiol       Date:  2014-10-30       Impact factor: 7.196

2.  Common clinical practice versus new PRIM score in predicting coronary heart disease risk.

Authors:  Ruth Frikke-Schmidt; Anne Tybjærg-Hansen; Peter Schnohr; Gorm B Jensen; Børge G Nordestgaard
Journal:  Atherosclerosis       Date:  2010-07-27       Impact factor: 5.162

3.  Context-dependent associations between variation in risk of ischemic heart disease and variation in the 5' promoter region of the apolipoprotein E gene in Danish women.

Authors:  Jari H Stengård; Greg Dyson; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen; Borge G Nordestgaard; Charles F Sing
Journal:  Circ Cardiovasc Genet       Date:  2009-12-03

4.  Efficient identification of context dependent subgroups of risk from genome-wide association studies.

Authors:  Greg Dyson; Charles F Sing
Journal:  Stat Appl Genet Mol Biol       Date:  2014-04-01

5.  Validated context-dependent associations of coronary heart disease risk with genotype variation in the chromosome 9p21 region: the Atherosclerosis Risk in Communities study.

Authors:  Christine M Lusk; Greg Dyson; Andrew G Clark; Christie M Ballantyne; Ruth Frikke-Schmidt; Anne Tybjærg-Hansen; Eric Boerwinkle; Charles F Sing
Journal:  Hum Genet       Date:  2014-06-03       Impact factor: 4.132

6.  An Application of the Patient Rule-Induction Method to Detect Clinically Meaningful Subgroups from Failed Phase III Clinical Trials.

Authors:  Greg Dyson
Journal:  Int J Clin Biostat Biom       Date:  2021-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.